Network Five: Episode 16 – Neurology
Guest Speakers – Dr Hugo Morales (neurologist), Dr James Tadros (emergency physician), Jessica Stabler (epilepsy fellow) and Sai Nagaratnam (neurology advanced trainee), Sydney – Australia.
In this first part of the series on neurology, we talk about vertigo and some tools that could improve the rate of diagnosis.
- Nham B, Reid N, Bein K, Bradshaw AP, McGarvie LA, Argaet EC, Young AS, Watson SR, Halmagyi GM, Black DA, Welgampola MS. Capturing vertigo in the emergency room: three tools to double the rate of diagnosis. J Neurol. 2022 Jan;269(1):294-306.
In this part, we explore the association between COVID-19 vaccination and Guillain-Barré Syndrome (GBS). The interlude segment will be presented by Dr Hugo Morales.
- Keh RYS, Scanlon S, Datta-Nemdharry P, Donegan K, Cavanagh S, Foster M, Skelland D, Palmer J, Machado PM, Keddie S, Carr AS, Lunn MP; BPNS/ABN COVID-19 Vaccine GBS Study Group. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database. Brain. 2022 Feb 18:awac067
In this segment, we discuss the efficacy of Levetiracetam, Fosphenytoin, and Valproate for status epilepticus. The interlude segment will be presented by Dr James Tadros.
- Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, Rogers A, Barsan W, Cloyd J, Lowenstein D, Bleck TP, Conwit R, Meinzer C, Cock H, Fountain NB, Underwood E, Connor JT, Silbergleit R; Neurological Emergencies Treatment Trials; Pediatric Emergency Care Applied Research Network investigators. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020 Apr 11;395(10231):1217-1224
Follow on Social Media
Listen in your favourite apps
Emergency Medicine Journal Club